高级检索
当前位置: 首页 > 详情页

VATS Versus Open Lobectomy in Pathological T1 SCLC: A Multi-Center Retrospective Analysis

文献详情

资源类型:
WOS体系:
Pubmed体系:

收录情况: ◇ SCIE

单位: [1]Zhejiang Univ, Affiliated Hosp 1, Dept Thorac Surg, Sch Med, 79 Qing Chun Rd, Hangzhou 310003, Zhejiang, Peoples R China [2]Tianjin Chest Hosp, Dept Thorac Surg, Tianjin, Peoples R China [3]Sichuan Univ, West China Hosp, Dept Thorac Surg, Chengdu, Peoples R China [4]Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Dept Thorac Surg, Wuhan, Peoples R China [5]Henan Canc Hosp, Dept Thorac Surg, Zhengzhou, Peoples R China [6]Fourth Mil Med Univ, Tangdu Hosp, Dept Thorac Surg, Xian, Peoples R China [7]Nanjing Med Univ, Canc Inst Jiangsu Prov, Affiliated Canc Hosp, Dept Thorac Surg, Nanjing, Peoples R China [8]Canc Inst Jiangsu Prov, Jiangsu Key Lab Mol & Translat Canc Res, Nanjing, Peoples R China [9]Chinese Peoples Liberat Army Gen Hosp, Dept Thorac Surg, Beijing, Peoples R China [10]Shanghai Chest Hosp, Dept Thorac Surg, Shanghai, Peoples R China [11]China Japan Friendship Hosp, Dept Thorac Surg, Beijing, Peoples R China [12]Linkdoc Technol Co Ltd, Med Affairs, Beijing, Peoples R China
出处:
ISSN:

关键词: SCLC VATS open lobectomy lymph node dissection surgery approach

摘要:
Studies of surgical approach selection for operable small cell lung cancer (SCLC) are lacking. We retrospectively enrolled 169 patients with pathologically confirmed T1 stage SCLC who underwent video-assisted thoracic surgery (VATS) or open lobectomy. Open surgery does not significantly increase the perioperative risk, but lymph node dissection can be done more thoroughly. The recommendation of VATS as a routine approach for SCLC surgery may still require further study, and until then, open surgery should still be considered. Background: Video-assisted thoracic surgery (VATS) has been widely used in the surgical treatment of thoracic diseases, and it suggested surgical and oncological advantages compared with open surgery. However, reports on the application of VATS in surgery of small cell lung cancer (SCLC) are scarce. This study aimed to explore the advantages and disadvantages of different surgical approaches in the treatment of pathological stage T1(pT1) SCLC in terms of safety, clinical outcomes, and lymph node dissection. Patients and Methods: Patients who underwent lobectomy for pT1 SCLC between January 2014 and September 2017 were identified from the National Collaborative Lung Cancer Database (LinkDoc Database). The patients were stratified based on the surgery approach (VATS or open lobectomy). Perioperative outcomes and long-term survival were analyzed using SPSS software. Results: A total of 169 patients with pT1 SCLC met the criteria and were enrolled for this study, including 110 cases of VATS lobectomies and 59 cases of open lobectomies. VATS lobectomy was associated with less blood loss than open surgery (168.1 +/- 237.4 vs. 340.0 +/- 509.8 mL, P = .002). Open lobectomy harvested more N2 LNs (11.8 +/- 8.2 vs. 8.4 +/- 5.8, P = .048) and identified more metastasis positive LNs (3.1 +/- 6.0 vs. 1.4 +/- 3.0, P = .050). Open lobectomy associated with longer overall survival (OS) but has no statistical difference (23.4 +/- 13.2 vs. 20.2 +/- 10.9, P = .070). Conclusion: Open lobectomy had better lymph node dissection results, and comparable postoperative complications, postoperative hospital stay, and OS to VATS lobectomy. Further studies may still be needed to confirm the recommendation of thoracoscopic approach as a routine surgical procedure for operable SCLC, and until then, open surgery should still be considered. (C) 2021 Elsevier Inc. All rights reserved.

基金:
语种:
被引次数:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2021]版:
大类 | 2 区 医学
小类 | 3 区 肿瘤学
最新[2025]版:
大类 | 3 区 医学
小类 | 3 区 肿瘤学
JCR分区:
出版当年[2020]版:
Q2 ONCOLOGY
最新[2023]版:
Q2 ONCOLOGY

影响因子: 最新[2023版] 最新五年平均 出版当年[2020版] 出版当年五年平均 出版前一年[2019版] 出版后一年[2021版]

第一作者:
第一作者单位: [1]Zhejiang Univ, Affiliated Hosp 1, Dept Thorac Surg, Sch Med, 79 Qing Chun Rd, Hangzhou 310003, Zhejiang, Peoples R China
通讯作者:
推荐引用方式(GB/T 7714):
APA:
MLA:

相关文献

资源点击量:428 今日访问量:0 总访问量:412 更新日期:2025-04-01 建议使用谷歌、火狐浏览器 常见问题

版权所有:重庆聚合科技有限公司 渝ICP备12007440号-3 地址:重庆市两江新区泰山大道西段8号坤恩国际商务中心16层(401121)